Treatment of Neuropsychiatric Symptoms in Alzheimer’s Disease with a Cannabis-Based Magistral...

Tue, Nov 5

More evidence that #CBD can help patients with #Alzheimers (and their families..) cope with disruptive behaviors (average dose of CBD was 111 mg) https://t.co/sJhlg7lzJ9

0125

Abstract. Introduction: Neuropsychiatric symptoms (NPS) may be disruptive and problematic for patients with Alzheimer’s disease (AD) and for their caregivers. Cannabidiol (CBD) may be a safer...

Discover